Get the Stockscreener App
89.85
0.84%
-0.76
Pre-market:
89.91
0.06
+0.07%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $89.85, with a volume of 5.81M.
It is down -0.84% in the last 24 hours and up +6.14% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$90.61
Open:
$90.57
24h Volume:
5.81M
Relative Volume:
0.99
Market Cap:
$71.90B
Revenue:
$20.80B
Net Income/Loss:
$2.22B
P/E Ratio:
34.86
EPS:
2.5772
Net Cash Flow:
$3.77B
1W Performance:
-0.19%
1M Performance:
+6.14%
6M Performance:
+12.26%
1Y Performance:
-2.96%
1-Day Range:
$89.46
$91.21
1-Week Range:
$88.37
$91.52
52-Week Range:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
89.85 | 72.51B | 20.80B | 2.22B | 3.77B | 2.5772 |
PG
Procter Gamble Co
|
142.96 | 336.34B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
57.07 | 124.58B | 56.67B | 6.96B | 7.39B | 3.1265 |
KVUE
Kenvue Inc
|
17.49 | 33.66B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
98.77 | 32.91B | 16.56B | 1.75B | 1.84B | 6.36 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Mar-31-26 | Downgrade | TD Cowen | Buy → Hold |
| Mar-30-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-13-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-07-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Market Crash: The 3 Best Dividend Stocks to Buy Right Now - The Motley Fool
Colgate FY26 net profit falls to Rs 1,325.31 Cr - scanx.trade
Colgate Palmolive India Shares Fall 3% On Mixed Brokerage View — Buy, Sell Or Hold? - NDTV Profit
Colgate-Palmolive India shares upgraded by Nomura, but majority analysts still say 'sell' - CNBC TV18
If you purchased Tom's toothpaste within the last 6 years, you could be eligible for a payout - MSN
Colgate-Palmolive’s SWOT analysis: stock faces cost pressures By Investing.com - Investing.com Nigeria
Colgate-Palmolive’s SWOT analysis: stock faces cost pressures - Investing.com
Colgate-Palmolive India leans on premium products, advertising to drive growth - The Economic Times
Colgate Q4 FY26 Net Sales Rise 9%; Declares Dividend - scanx.trade
Colgate-Palmolive India Q4 profit down marginally to Rs 353 cr; FY26 revenue dips to Rs 6,124 cr - The Economic Times
Colgate Palmolive India's quarterly adjusted profit rises on demand for premium products - Reuters
Rathbones Group PLC Increases Stock Position in Colgate-Palmolive Company $CL - MarketBeat
PNC Financial Services Group Inc. Sells 62,956 Shares of Colgate-Palmolive Company $CL - MarketBeat
CL Price Today: Colgate-Palmolive Company Stock Price, Quote & Chart | MEXC - MEXC
Household Cleaning Products Market is expected to Hit US$ 65.2 - openPR.com
HighTower Advisors LLC Cuts Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Co stock (US1845021021): strong Q1 momentum and raised outlook draw investor focus - AD HOC NEWS
Colgate-Palmolive execs speak at global consumer conference in Paris - Stock Titan
Is CL Overvalued? DCF Says Worth $43 - GuruFocus
3 Stocks With Rare Bearish Price Targets From Wall Street Analysts (CL, FCEL, FHI)News and Statistics - IndexBox
Global Oral Care Market Outlook 2026-2036: Daily Replenishment Demand and Premiumization Drive Growth for Colgate-Palmolive, Procter & Gamble, and Unilever - PR Newswire UK
AMF Tjanstepension AB Trims Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Oil Prices Surge Amid U.S.-Iran Tensions and Low Global Stocks - GuruFocus
Colgate Palmolive (CL) EVP sells 2,300 shares at $88.44 - Stock Titan
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
Colgate-Palmolive May Be Boring, But CL Stock Has Great Upside Potential Here - Barchart.com
Blume Capital Management Inc. Purchases 20,380 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate’s ‘Every Smile Has a Story’ Shares Family Moments From Across Asia-Pacific - Branding in Asia
What is Zacks Research's Forecast for CL Q2 Earnings? - MarketBeat
Oil Prices Rise Amid Escalating Middle East Tensions - GuruFocus
Colgate-Palmolive Co stock (US1845021021): solid growth and guidance debate after latest earnings - AD HOC NEWS
Consumer Staples Stocks Analysis – Coty, Colgate-Palmolive, Philip Morris (May 2026)News and Statistics - IndexBox
Canada Post Corp Registered Pension Plan Has $6.02 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Accredited Investors Inc. Acquires Shares of 11,953 Colgate-Palmolive Company $CL - MarketBeat
CL Stock Price and Chart — NYSE:CL - TradingView
Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets - Insider Monkey
Why Colgate's Innovation Strategy Is Fueling Market Share Gains - Yahoo Finance UK
BNY Mellon Dynamic Value Fund's Colgate-Palmolive Co(CL) Holding History - GuruFocus
Top Colgate-Palmolive (CL) Competitors 2026 - MarketBeat
Colgate-Palmolive (CL): The Best Stock to Buy in Falling Markets According to Wall Street Analysts - Insider Monkey
Oil Prices Drop as Vessels Navigate Hormuz Strait - GuruFocus
CL Stock Chart | COLGATE-PALMOLIVE CO (NYSE:CL) - ChartMill
Colgate-Palmolive (India) stock (INE259A01022): Steady performer in India's oral care market - AD HOC NEWS
Colgate-Palmolive (CL) Announces Results of Annual Stockholders Meeting - GuruFocus
Director at Colgate-Palmolive (NYSE: CL) receives stock and option awards - Stock Titan
Colgate-Palmolive (CL) director Newman granted shares and options in annual equity awards - Stock Titan
Colgate-Palmolive (CL) director receives stock grant and 2,424-share option award - Stock Titan
Colgate-Palmolive (NYSE: CL) director awarded new stock and options - Stock Titan
Director at Colgate (NYSE: CL) receives stock grant and options - Stock Titan
Colgate-Palmolive (CL) director awarded shares and 2,424 stock options - Stock Titan
Colgate (NYSE: CL) director John Cahill receives stock and option grants - Stock Titan
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):